JESSICA WEIGAND: Open Payments
NPI 1669911152 · ZANESVILLE, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,890 in 123 payments from 17 companies in 2025. Trend: 2023 $6,448 · 2024 $6,185 · 2025 $9,890
Speaker / faculty: $8,000Food & beverage: $1,807Travel & lodging: $83
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $8,339 |
| Alkermes, Inc. | 17 | $271 |
| Supernus Pharmaceuticals, Inc. | 17 | $195 |
| Lundbeck LLC | 11 | $171 |
| Janssen Pharmaceuticals, Inc | 7 | $168 |
| Otsuka America Pharmaceutical, Inc. | 10 | $149 |
| Tris Pharma Inc | 6 | $108 |
| Neurocrine BioSciences, Inc. | 5 | $89 |
| Teva Pharmaceuticals USA, Inc. | 5 | $84 |
| E.R. Squibb & Sons, L.L.C. | 2 | $70 |
Products named: VRAYLAR, Qelbree, REXULTI, ARISTADA, ABILIFY MAINTENA, INVEGA, LYBALVI, Dyanavel XR.
Industry payments across OH — which companies pay providers there.
